✦ LIBER ✦

Cost Efficacy of Platelet Glycoprotein IIb/IIIa Antagonists in Clinical Trials and Clinical Practice

✍ Scribed by JOHN J. YOUNG; DEAN J. KEREIAKES

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Three Different Glycoprotein I

✍ S. Rajendran; R. Gupta; J. Luu; D. Parikh; P. Diu; I. Shugman; S. Lo; J. French; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Impact of Three Different Glycoprotein I

✍ Rohan Gupta; Patrick Diu; Tuan Nguyen; Kishor Kadappu; Saissan Rajendran; Sidney 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

“COAT” platelets: A clue to the lack of

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 20 KB

Overview of clinical trials of glycoprot

✍ Robert A. Harrington 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Platelet glycoprotein IIb/IIIa inhibitor

✍ E. Boersma; R.A. Harrington; D.J. Moliterno 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Platelet glycoprotein IIb/IIIa inhibitor

✍ Eric Boersma; Robert A Harrington; David J Moliterno; Harvey White; Pierre Théro 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 128 KB